首页> 美国卫生研究院文献>Springer Open Choice >A prospective double-blind randomized two-period crossover multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study)

【2h】

A prospective double-blind randomized two-period crossover multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study)

机译：前瞻性双盲随机两期交叉多中心研究用于评估膀胱过度活动症患者的米拉贝隆和托特罗定之间的耐受性和患者偏爱（PREFER研究）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Introduction and hypothesisThe objective of this study was to assess the tolerability and treatment preference in patients with overactive bladder (OAB) treated with mirabegron or tolterodine.

机译：引言和假设本研究的目的是评估接受米拉贝隆或托特罗定治疗的膀胱过度活动症（OAB）患者的耐受性和治疗偏好。

著录项

期刊名称 Springer Open Choice
作者
David Staskin; Sender Herschorn; Jonathan Fialkov; Le Mai Tu; Terry Walsh; Carol R. Schermer;
展开▼
作者单位

展开▼
年(卷),期 -1(29),2
年度 -1
页码 273–283
总页数 11
原文格式 PDF
正文语种
中图分类外科学;
关键词
Crossover study Mirabegron Tolterodine OAB-S Medication Tolerability scale Patient preference Anticholinergic side effects;

机译：交叉研究;米拉贝格隆;托特罗定;OAB-S药物耐受性量表;患者偏爱;抗胆碱能副作用;

相似文献

外文文献
中文文献
专利

1. A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study) [J] . David Staskin, Sender Herschorn, Jonathan Fialkov, International urogynecology journal and pelvic floor dysfunction . 2018,第2期

机译：一种前瞻性，双盲，随机，两期交叉，多中心研究，以评估膀胱过度活性膀胱患者M拉萨比顿和甲苯酮肽（更喜欢研究）的耐受性和患者偏好
2. Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER) [J] . Sender Herschorn, David Staskin, Le Mai Tu, Health and Quality of Life Outcomes . 2018,第1期

机译：患者报告的过度活性膀胱患者的结果，在前瞻性，双盲，随机，两期交叉，多中心研究（更喜欢）
3. A PHASE 4, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTRE STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF MIRABEGRON IN OLDER ADULT PATIENTS WITH OVERACTIVE BLADDER SYNDROME (PILLAR) [J] . Wagg A., Staskin D., Engel E., Neurourology and urodynamics. . 2018,第Suppla5期

机译：阶段4，双盲，随机，安慰剂控制，并行组，多中心研究，评价Mirabegron在老年成年患者过度活跃的膀胱综合征（柱）中的疗效，安全性和耐受性
4. Electrical Stimulation of the Transcutaneous Posterior Tibial Nerve for the Treatment of Patients with Detrusor Overactivity Due to Neurogenic Hiperactive Bladder in Multiple Sclerosis A Case Study [C] . Fabiana S. B. Perez, Luciana R. Tenorio Peixoto, Fabiano Soares, International Conference on Biomedical Electronics and Devices . 2014

机译：经皮后胫骨神经的电气刺激治疗多发性硬化中神经源性膀胱患者患者的患者案例研究
5. A double-blind, placebo-control, randomized study investigating the neuropsychological effects of Zyprexa in patients who stutter. [D] . Franklin, David Lawrence. 2003

机译：一项双盲，安慰剂对照的随机研究，研究了Zyprexa对口吃患者的神经心理影响。
6. Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective double-blind randomized two-period crossover multicenter study (PREFER) [O] . Sender Herschorn, David Staskin, Le Mai Tu, 2018

机译：在一项前瞻性双盲随机两周期交叉多中心研究（PREFER）中接受米拉贝隆和托特罗定治疗的膀胱过度活动症患者的患者报告结局
7. A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study) [O] . David Staskin, Sender Herschorn, Jonathan Fialkov, 2017

机译：一种预期，双盲，随机，两期交叉，多中心研究，以评估甲哌罗罗罗朗与甲醛患者过度活跃膀胱患者的耐受性和患者偏好（更喜欢研究）

A prospective double-blind randomized two-period crossover multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study)

摘要

著录项

相似文献

相关主题

期刊订阅